Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.07
+0.06 (0.86%)
At close: Jul 24, 2026, 4:00 PM EDT
7.02
-0.05 (-0.71%)
After-hours: Jul 24, 2026, 7:41 PM EDT
Sagimet Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
436.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 2.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Prothena Corporation | 57.94M |
| Editas Medicine | 38.69M |
| C4 Therapeutics | 34.86M |
| Evommune | 10.00M |
| Ovid Therapeutics | 7.12M |
| Ocugen | 4.47M |
| ProKidney | 889.00K |
SGMT News
- 26 days ago - Sagimet Biosciences joins Russell 3000, Russell 2000 Indexes - TheFly
- 26 days ago - Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 4 weeks ago - Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH - GlobeNewsWire
- 2 months ago - Sagimet Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 2 months ago - Sagimet Biosciences price target lowered to $12 from $35 at Citizens - TheFly
- 2 months ago - Sagimet Biosciences price target lowered to $28 from $37 at Clear Street - TheFly
- 2 months ago - Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire